Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply

Aliment Pharmacol Ther. 2020 Jun;51(11):1200-1201. doi: 10.1111/apt.15724.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Disease Progression
  • Fibrosis
  • Humans
  • Liver Cirrhosis
  • Medicare
  • Non-alcoholic Fatty Liver Disease*
  • United States